Quarterly report pursuant to Section 13 or 15(d)

Non-controlling Interest and Related Party (Details)

v3.22.1
Non-controlling Interest and Related Party (Details) - USD ($)
3 Months Ended
Sep. 05, 2018
Mar. 31, 2022
Mar. 31, 2021
Noncontrolling Interest      
Related Party Transaction, Expenses from Transactions with Related Party $ 328,000    
Net Income (Loss) Attributable to Noncontrolling Interest   $ 0 $ (1,000)
SYN Biomics [Member]      
Noncontrolling Interest      
Equity Method Investment, Ownership Percentage   100.00%  
Related Party Transaction, Expenses from Transactions with Related Party     $ 0
Cedarssinai Medical Center [Member]      
Noncontrolling Interest      
Number Of Common Stock To Be Issued 50,000    
Fair Value Of Shares Issued $ 285,000    
Cedarssinai Medical Center [Member] | SYN Biomics [Member]      
Noncontrolling Interest      
Additional Number Of Common Stock To Be Issued 2,420,000    
Number Of Common Stock To Be Held By Related Party 7,480,000    
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners 17.00%